Feasibility Study of Particulate Extracellular Matrix (P-ECM) and Left Ventricular Assist Device (HVAD) Therapy in Chronic Ischemic Heart Failure Bovine Model
Kevin G. Soucy(Johns Hopkins University), Mark S. Slaughter(University of Louisville), Robert G. Matheny(CorMatrix (United States)), B Keller(University of Louisville), Gregg Rokosh(University of Louisville), Erin Smith(University of Louisville), Steven C. Koenig(University of Louisville), Guruprasad A. Giridharan(University of Louisville), Anna M. Fallon(CorMatrix (United States)), Gretel Monreal(University of Louisville), Beecher C. Lewis(CorMatrix (United States)), Michael A. Sobieski(University of Louisville), Fangping Yuan(University of Louisville), Leslie C. Sherwood(University of Louisville)
Cited by 24
Related Papers
Clinical management of continuous-flow left ventricular assist devices in advanced heart failure
|The Journal of Heart and Lung Transplantation|2010|876
Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure
|New England Journal of Medicine|2017|757
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke
|New England Journal of Medicine|2021|711
Use of an Intrapericardial, Continuous-Flow, Centrifugal Pump in Patients Awaiting Heart Transplantation
|Circulation|2012|655
Continuous Flow Left Ventricular Assist Device Improves Functional Capacity and Quality of Life of Advanced Heart Failure Patients
|Journal of the American College of Cardiology|2010|583